These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34431461)

  • 1. Lipid-based Nanocarriers Loaded with Taxanes for the Management of Breast Cancer: Promises and Challenges.
    Chaurawal N; Misra C; Raza K
    Curr Drug Targets; 2022; 23(6):544-558. PubMed ID: 34431461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promises of Lipid-based Drug Delivery Systems in the Management of Breast Cancer.
    Thotakura N; Gupta MM; Rajawat JS; Raza K
    Curr Pharm Des; 2021; 27(45):4568-4577. PubMed ID: 34323182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review.
    Kothapalli P; Vasanthan M
    Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer.
    Mukherjee D; Raikwar S
    AAPS PharmSciTech; 2024 Jul; 25(6):153. PubMed ID: 38961013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications.
    Harshita ; Barkat MA; Das SS; Pottoo FH; Beg S; Rahman Z
    Curr Pharm Des; 2020; 26(11):1167-1180. PubMed ID: 32026769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catanionic Hybrid Lipid Nanovesicles for Improved Bioavailability and Efficacy of Chemotherapeutic Drugs.
    Xie X; He D; Wu Y; Wang T; Zhong C; Zhang J
    Methods Mol Biol; 2021; 2211():57-68. PubMed ID: 33336270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches.
    Aslam M; Javed MN; Deeb HH; Nicola MK; Mirza MA; Alam MS; Akhtar MH; Waziri A
    CNS Neurol Disord Drug Targets; 2022; 21(10):952-965. PubMed ID: 34967302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
    Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel taxanes in development: Hopes or hypes?
    Lei L; Wang XJ; Tang SC
    Crit Rev Oncol Hematol; 2022 Aug; 176():103727. PubMed ID: 35644326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current approaches in lipid-based nanocarriers for oral drug delivery.
    Plaza-Oliver M; Santander-Ortega MJ; Lozano MV
    Drug Deliv Transl Res; 2021 Apr; 11(2):471-497. PubMed ID: 33528830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.
    Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K
    Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Lipid-Based Nanocarriers for Increasing Gastrointestinal Absorption of Lupinifolin.
    Musika J; Chudapongse N
    Planta Med; 2020 Mar; 86(5):364-372. PubMed ID: 32005042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Based Nanocarriers for Lymphatic Transportation.
    Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
    AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Strategies and Challenges for Controlled Delivery of Taxanes: A Comprehensive Review.
    Mahajan M; Khurana RK; Sahajpal NS; Utreja P; Sankar R; Singh B; Jain SK
    Curr Drug Metab; 2015; 16(6):453-73. PubMed ID: 26264203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 18. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics.
    Garg NK; Singh B; Jain A; Nirbhavane P; Sharma R; Tyagi RK; Kushwah V; Jain S; Katare OP
    Colloids Surf B Biointerfaces; 2016 Oct; 146():114-26. PubMed ID: 27268228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid based nanocarriers: a translational perspective.
    Mishra DK; Shandilya R; Mishra PK
    Nanomedicine; 2018 Oct; 14(7):2023-2050. PubMed ID: 29944981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
    Teixeira MC; Carbone C; Souto EB
    Prog Lipid Res; 2017 Oct; 68():1-11. PubMed ID: 28778472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.